Screening for Colorectal Cancer in a Safety-Net Health Care System: Access to Care Is Critical and Has Implications for Screening Policy

Background: Data on the number of individuals eligible for screening, and rates of screening, are necessary to assess national colorectal cancer screening efforts. Such data are sparse for safety-net health systems. Methods: A retrospective cohort study of individuals ages 50 to 75 served by a safety-net health system in Tarrant County, TX was conducted to determine (a) the size of the potential screen-eligible population ages 50 to 75, (b) the rate of screening over 5 years among individuals ages 54 to 75, and (c) the potential predictors of screening, including sex, race/ethnicity, insurance status, frequency of outpatient visits, and socioeconomic status. Results: Of 28,708 potential screen-eligible individuals, 20,416 were ages 54 to 75 and analyzed for screening; 22.0% were screened within the preceding 5 years. Female gender, Hispanic ethnicity, ages 65 to 75, insurance status, and two or more outpatient visits were independently associated with screening. Access to care was an important factor: adjusted odds ratio, 2.57 (95% confidence interval, 2.23-2.98) for any insurance; adjusted odds ratio, 3.53 (95% confidence interval, 3.15-3.97) for two or more outpatient visits. Conclusions: The screen-eligible population served by our safety-net health system was large, and the projected deficit in screen rates was substantial. Access to care was the dominant predictor of screening participation. If our results are replicable in similar health systems, the data suggest that screening guidelines and policy efforts must take into account the feasibility of proposed interventions. Strong advocacy for more resources for colorectal cancer screening interventions (including research into the best manner to provide screening for large populations) is needed. (Cancer Epidemiol Biomarkers Prev 2009;18(9):2373–9)

[1]  R. Cardarelli,et al.  Having a Personal Health Care Provider and Receipt of Colorectal Cancer Testing , 2009, The Annals of Family Medicine.

[2]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[3]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[4]  R. Coates,et al.  Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005. , 2008, American journal of preventive medicine.

[5]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[6]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[7]  H. Beydoun,et al.  Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States , 2008, Cancer Causes & Control.

[8]  D. Ransohoff,et al.  Evaluation of Claims, Medical Records, and Self-report for Measuring Fecal Occult Blood Testing among Medicare Enrollees in Fee for Service , 2008, Cancer Epidemiology Biomarkers & Prevention.

[9]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[10]  G. Cooper,et al.  Underuse of colorectal cancer screening in a cohort of medicare beneficiaries , 2008, Cancer.

[11]  D. Ransohoff,et al.  Data Sources for Measuring Colorectal Endoscopy Use Among Medicare Enrollees , 2007, Cancer Epidemiology Biomarkers & Prevention.

[12]  L. Seeff,et al.  Colorectal Cancer Test Use Among Hispanic and Non-Hispanic U.S. Populations , 2006, Preventing chronic disease.

[13]  J. Faivre,et al.  Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. , 2004, Gastroenterology.

[14]  Linda Rabeneck,et al.  Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System , 2003, American Journal of Gastroenterology.

[15]  Jarvis T. Chen,et al.  Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. , 2002, American journal of epidemiology.

[16]  S V Subramanian,et al.  Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas--the Public Health Disparities Geocoding Project. , 2002, American journal of public health.

[17]  T. Ben-Menachem,et al.  Sociodemographic Differences in the Receipt of Colorectal Cancer Surveillance Care Following Treatment With Curative Intent , 2001, Medical care.

[18]  A. Jha,et al.  Racial differences in mortality among men hospitalized in the Veterans Affairs health care system. , 2001, JAMA.

[19]  S. Altman,et al.  America's Health Care Safety Net: Intact but Endangered , 2000 .

[20]  T. Church,et al.  Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. , 1999, Journal of the National Cancer Institute.

[21]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[22]  R. Andersen Revisiting the behavioral model and access to medical care: does it matter? , 1995, Journal of health and social behavior.

[23]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[24]  S. Moss,et al.  RANDOMISED, CONTROLLED TRIAL OF FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCER Results for First 107 349 Subjects , 1989, The Lancet.

[25]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[26]  Michael Halpern,et al.  Association of Insurance with Cancer Care Utilization and Outcomes , 2008, CA: a cancer journal for clinicians.

[27]  Use of colorectal cancer tests--United States, 2002, 2004, and 2006. , 2008, MMWR. Morbidity and mortality weekly report.

[28]  Avery S. Hart,et al.  America's Health Care Safety Net: Intact but Endangered , 2000 .

[29]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.